메뉴 건너뛰기




Volumn 425, Issue , 2013, Pages 1-2

Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer

Author keywords

Anti EGFR; Colorectal carcinoma; LightCycler; RAS

Indexed keywords

DNA;

EID: 84881256021     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.06.025     Document Type: Article
Times cited : (10)

References (5)
  • 1
    • 0024376173 scopus 로고
    • RAS oncogenes in human cancer: a review
    • Bos J.L. RAS oncogenes in human cancer: a review. Can Res 1989, 49:4682-4689.
    • (1989) Can Res , vol.49 , pp. 4682-4689
    • Bos, J.L.1
  • 3
    • 42649145667 scopus 로고    scopus 로고
    • Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
    • Amado R.G., Wolf M., Peeters M., et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 2008, 26:1626-1634.
    • (2008) J Clin Oncol , vol.26 , pp. 1626-1634
    • Amado, R.G.1    Wolf, M.2    Peeters, M.3
  • 5
    • 77956238031 scopus 로고    scopus 로고
    • NRAS mutations are rare in colorectal cancer
    • Irahara N., Baba Y., Nosho K., et al. NRAS mutations are rare in colorectal cancer. Diagn Mol Pathol 2010, 19:157-163.
    • (2010) Diagn Mol Pathol , vol.19 , pp. 157-163
    • Irahara, N.1    Baba, Y.2    Nosho, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.